The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Bone-Marrow Transplantation in a Patient with Sickle-Cell Anemia
Abstract
SICKLE-CELL anemia affects 1 in 600 of the U.S. black population and accounts for 80,000 deaths annually throughout the world.1 , 2 Current therapy is designed to prevent sickle-cell crises, but supportive care remains the only treatment available once they occur. Attempts to alter the expression of hemoglobin genes in β-thalassemia and sickle-cell anemia with the use of azacytidine have produced only transient effects.3 This report describes the conversion of sickle-cell anemia to sickle-cell trait by marrow transplantation (done for treatment of leukemia) in a child with both sickle-cell anemia and acute myeloblastic leukemia. It raises the possibility of using marrow transplantation . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Allogeneic hematopoietic stem and progenitor cell (HSPC) transplantation (allo-HSCT) can provide a one-time and life-long cure for patients with serious genetic hematological diseases such as primary immunodeficiencies20 and hemoglobinopathies21,22, if a suitable immunologically matched donor can be found23.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [21]
Citations
Cites
Bone-Marrow Transplantation: (First of Two Parts)
Thomas, E. D., Storb, R., Clift, R. A., Fefer, A., Johnson, F. L., Neiman, P. E., Lerner, K. G., Glucksberg, H., & Buckner, C. D. (1975) · New England Journal of Medicine · doi:10.1056/nejm197504172921605 · Cited by 1,693
5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia
Ley, T. J., DeSimone, J., Anagnou, N. P., Keller, G. H., Humphries, R. K., Turner, P. H., Young, N. S., Heller, P., & Nienhuis, A. W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072401 · Cited by 490
Frequency of Sickling Disorders in U.S. Blacks
Motulsky, A. G. (1973) · New England Journal of Medicine · doi:10.1056/nejm197301042880108 · Cited by 212
SICKLE CELL ANEMIA TERMINATING IN ACUTE MYELOBLASTIC LEUKEMIA
GOLDIN, A. G., KELTY, K. C., & Beard, M. F. (1953) · Annals of Internal Medicine · doi:10.7326/0003-4819-39-4-920 · Cited by 23
Sickle cell anemia with acute myeloid leukemia--(a case report).
Gc, S. (1979) · PubMed · Cited by 16
Research works printed but not linked: 3
- Lehmann H, Huntsman RS, Casey R, et al. Sickle cell disease and related disorders. In: Williams WJ, Beutler E, Erslev AJ, Rundles RW, eds. Hematology. 2nd ed. New York: McGraw-Hill, 1977:495–523.
- Kalwinsky, 1983, Proc Am Soc Clin Oncol, 2, 171
- Samal, 1979, Indian Pediatr, 16, 453
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Vakulskas, C. A., Dever, D. P., Rettig, G. R., Turk, R., Jacobi, A. M., Collingwood, M. A., Bode, N. M., McNeill, M. S., Yan, S., Camarena, J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0137-0 · Cited by 782
Serjeant, G. R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07330-3 · Cited by 762
Bone Marrow Transplantation for Sickle Cell Disease
Walters, M. C., Patience, M., Leisenring, W., Eckman, J. R., Scott, J. P., Mentzer, W. C., Davies, S. C., Ohene-Frempong, K., Bernaudin, F., Matthews, D. C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350601 · Cited by 627
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Bernaudin, F., Socie, G., Kuentz, M., Chevret, S., Duval, M., Bertrand, Y., Vannier, J.-P., Yakouben, K., Thuret, I., Bordigoni, P., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079665 · Cited by 515
“Median ferritin level, ng/mL (range) 374 (13-3820) 792 (340-2059) 604 (31-3171) 553 (13-3820)”
Metadata
- Authors
- Johnson, F. L., Look, A. T., Gockerman, J., Ruggiero, M. R., Dalla-Pozza, L., & Billings, F. T.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1984-09-20
- Volume
- 311
- Issue
- 12
- Pages
- 780-783
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2077174747
- Semantic Scholar
- d66f6282a88e1bcef36117031477c0379471d396
- Cited by
- 321
- References
- 5
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 12 · 2023: 10 · 2022: 12 · 2021: 20 · 2020: 19 · 2019: 10 · 2018: 12 · 2017: 21 · 2016: 14 · 2015: 10 · 2014: 12 · 2013: 11 · 2012: 9
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Keywords
- sickle cell disease, bone marrow transplantation, acute myeloid leukemia, pediatric leukemia, hemoglobin gene expression, azacitidine, vaso-occlusive crisis
- MeSH terms
- Anemia, Sickle Cell, Child, Female, Glycated Hemoglobin, Hemoglobin A2, Hemoglobin, Sickle, Humans, Male, Sickle Cell Trait, Leukemia, Myeloid, Acute, Bone Marrow Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone-Marrow Transplantation in a Patient with Sickle-Cell Anemia. https://app.cochat.ai/papers/10.1056/nejm198409203111207
- The paper
- Johnson, F. L., Look, A. T., Gockerman, J., Ruggiero, M. R., Dalla-Pozza, L., & Billings, F. T. (1984). Bone-Marrow Transplantation in a Patient with Sickle-Cell Anemia. New England Journal of Medicine. https://doi.org/10.1056/nejm198409203111207
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.